Data / Research funding / Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia: 21 NIH awards ($19.1M), fiscal years 2021 to 2026
Universidad Peruana Cayetano Heredia in Lima is funded under 21 NIH awards ($19.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- R2CESKBNTS36UEI
Awards
21 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,214,806 | September 30, 2020 | January 31, 2027 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,400,684 | September 1, 2023 | May 31, 2028 | GARCIA, HECTOR HUGO | reporter.nih.gov |
| A Non-Inferiority Randomized Single Blind Controlled Trial Comparing One and Two Dose Regimes of Oxfendazole versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,550,376 | August 17, 2023 | July 31, 2028 | GARCIA, HECTOR HUGO | reporter.nih.gov |
| 1/2 - Regional GEOhealth Hub Centered In Peru-Peru | NIH | Fogarty International Center | 2022 to 2025 | $1,498,431 | September 28, 2015 | February 28, 2027 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| Emerge, Leaders in Emerging Diseases Epidemiology Research Training | NIH | Fogarty International Center | 2021 to 2025 | $1,457,032 | September 1, 2005 | April 30, 2030 | LESCANO, ANDRES G | reporter.nih.gov |
| Training in Infectious Diseases in Peru - Time for Implementation Research | NIH | Fogarty International Center | 2021 to 2025 | $1,455,601 | July 1, 1999 | February 28, 2027 | GARCIA, HECTOR HUGO | reporter.nih.gov |
| Program for Advanced ReseArch Capacities for AIDS in Peru (PARACAS): harnessing implementation science to enhance care and reduce transmission of HIV | NIH | Fogarty International Center | 2021 to 2024 | $1,168,152 | August 11, 2014 | December 31, 2025 | GOTUZZO, EDUARDO | reporter.nih.gov |
| Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country | NIH | Fogarty International Center | 2022 to 2025 | $659,105 | August 1, 2022 | June 30, 2027 | SCHIAFFINO, FRANCESCA | reporter.nih.gov |
| Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study) | NIH | National Heart, Lung, and Blood Institute | 2021 | $635,044 | September 30, 2020 | December 31, 2022 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| A mobile phone short message service intervention to increase retention in HIV care among HIV-positive men who have sex with men in Peru (WelTel Peru) | NIH | Fogarty International Center | 2021 to 2024 | $577,908 | August 17, 2020 | July 31, 2025 | MENACHO ALVIRIO, LUIS ALBERTO | reporter.nih.gov |
| Improving Diagnostic and Management Tools for Neurocysticercosis (Peru-JHU TMRC Program) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $547,763 | April 15, 2017 | March 31, 2023 | GARCIA, HECTOR HUGO | reporter.nih.gov |
| Understanding Immune Modulation in Taenia solium neurocysticercosis by using a novel postoncosphere in vitro model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $537,788 | May 1, 2020 | April 30, 2026 | VERASTEGUI, MANUELA RENEE | reporter.nih.gov |
| Research Ethics Training in latinAMericA (RETAMA) | NIH | Fogarty International Center | 2024 to 2025 | $498,242 | April 1, 2024 | March 31, 2029 | OCHOA, THERESA J | reporter.nih.gov |
| Alternative therapeutic approaches for the control of brain inflammation secondary to antihelminthic therapy in neurocysticercosis using a novel experimental pig model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $404,160 | March 8, 2019 | February 28, 2025 | ARROYO, GIANFRANCO | reporter.nih.gov |
| Improving HIV and STI Prevention and Care for Venezuelan Sexual and Gender Minority Migrants in Lima, Peru | NIH | National Institute of Mental Health | 2023 | $317,220 | September 21, 2023 | September 19, 2025 | SILVA-SANTISTEBAN, ALFONSO | reporter.nih.gov |
| The effect of Strongyloides stercoralis on HTLV-1 disease progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $270,000 | March 1, 2018 | February 29, 2024 | MONTES, MARTIN | reporter.nih.gov |
| Patient-centered intervention to prevent tuberculosis among children < 5 years old | NIH | Fogarty International Center | 2021 to 2022 | $266,004 | September 16, 2018 | February 29, 2024 | OTERO, LARISSA | reporter.nih.gov |
| Research Training: Chronic Non-Communicable CVDs and Comorbidities in Peru | NIH | Fogarty International Center | 2025 | $247,815 | August 11, 2025 | July 31, 2026 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| Using Burden of Treatment as a Clinical Indicator of Barriers to Multimorbidity Management in Peru: A Mixed Methods Approach | NIH | Fogarty International Center | 2021 | $145,903 | September 15, 2020 | June 30, 2025 | CUBA , MARIA SOFIA | reporter.nih.gov |
| Isolation and identification of CXCR4 and CXCR7 agonists from traditional phytopharmaceuticals as potential novel drugs for mental disorders | NIH | Fogarty International Center | 2021 | $134,962 | August 1, 2020 | July 31, 2025 | GALLO, CARLA | reporter.nih.gov |
| Planning an MD-MSc combined degree program focused on translational research to build the next generation of physician-scientist in Peru | NIH | Fogarty International Center | 2021 | $108,000 | July 30, 2020 | March 31, 2024 | MONTES, MARTIN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 9 | $4,492,620 | 0 | $0 |
| 2024 | 11 | $4,729,110 | 0 | $0 |
| 2023 | 12 | $4,615,279 | 0 | $0 |
| 2022 | 10 | $2,123,831 | 0 | $0 |
| 2021 | 13 | $3,134,156 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants | PAR-26-144 | NIH | 93.989 | November 15, 2026 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.989 | November 16, 2026 | $50,000 | Same assistance listing 93.989 as 12 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.989 | November 18, 2026 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 12 awards here |
| International Research Scientist Development Award (IRSDA) | PAR-28-040 | NIH | 93.989 | February 9, 2027 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes | PAR-28-039 | NIH | 93.989 | February 11, 2027 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Implementation and Evaluation of Databases to Examine AIDS | RFA-AI-28-025 | NIH | 93.989 | May 27, 2027 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) | RFA-TW-28-001 | NIH | 93.989 | September 22, 2027 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Emerging Global Leader Award (K43) | PAR-28-070 | NIH | 93.989 | October 12, 2027 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-25-143 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-25-233 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | PA-26-001 | NIH | 93.989 | November 30, 2028 | Not listed | Same assistance listing 93.989 as 12 awards here |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) | PA-26-002 | NIH | 93.989 | May 7, 2029 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) | PAR-28-090 | NIH | 93.989 | May 25, 2029 | Not listed | Same assistance listing 93.989 as 12 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 6 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 6 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 6 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 6 awards here |
Topics of its NIH awards
- Clinical Research
- Infectious Diseases
- Prevention
- Rare Diseases
- Behavioral and Social Science
- Clinical Trials and Supportive Activities
- Social Determinants of Health
- Brain Disorders
- Neurosciences
- Dissemination and Implementation Research
- Health Services
- Comparative Effectiveness Research
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.